Women’s health enters a new era – the trends shaping femtech in 2026

Almost 10 years after the term ‘femtech’ was coined, is the sector on the brink of its biggest transformation yet?

In 2026, experts say women’s health will finally shift from basic tracking to measurable biomarkers, AI-enabled personalisation and deeply women-centred care. We take a look at the trends set to define femtech next year.

A decade on from when Ida Tin first coined the term ‘femtech’, the industry could be shaping up to see some of its most significant advances yet.

Insights from legal, clinical and industry leaders reveal a future defined by measurable biometrics, AI-enabled personalisation, and a long-overdue shift toward women-centred care.

From hyper-personalised care to menstrual blood diagnostics, we delve into some of the major trends expected to shape the femtech sector in 2026.

Hyper-personalised, women-centred care becomes the norm

For decades, women’s health tools have been built on incomplete data sets and assumptions that failed to reflect real hormonal, emotional or life-stage complexity, but 2026 could be a ‘defining year’ for femtech as the industry shifts from “generic solutions toward deeply personalised and truly women-centred care,” Anastasia Shubareva-Epshtein, founder & CEO of Carea, tells Femtech World.

“Advances in AI will accelerate this shift. In 2026, we will see digital health platforms capable of delivering support that adapts to a woman’s individual biology, emotional state and daily experience.”

Devices such as the Oura Ring and continuous glucose monitors are already capturing cycle and hormonal signals. In 2026, we could see this data being harnessed by healthcare systems, enabling earlier intervention and more personalised care.

“In 2026, Femtech will shift from reactive tracking to proactive, personalised health management – covering pregnancy, menopause, and autoimmune conditions,” says Charlotte Lewis, principal associate at UK law firm Mills & Reeve.

“Three trends dominate globally: AI-driven symptom analysis predicting issues before they arise; fertility and pregnancy apps transforming into real-time health coaches; and seamless integration of wearable data into healthcare systems. Devices like the Oura Ring and continuous glucose monitors promise actionable insights on cycles, hormones, and fertility.”

Femtech shifts from tracking to measurable data collection

Alongside this, femtech could finally move beyond basic symptom tracking into quantifiable biomarker collection, according to Justyna Strzeszynska, women’s health expert and founder & CEO of Joii.

“Across FemTech, from menstrual health to fertility, menopause and broader endocrine conditions, there’s a growing realisation that women have been expected to self-report symptoms without being given meaningful clinical metrics. That’s starting to change,” she tells Femtech World.

“The next wave of FemTech will be driven by biomarkers, not just tracking.”

Lewis agrees: “Women’s health tech is evolving from simple tracking to predictive coaching.”

AI becomes ‘practical partner’ for women

AI is not going anywhere, and in 2026, it is likely to play a big role in the shift toward measurable, clinical-grade data collection.

“Not in a ‘black box diagnoses everything’ way,” says Strzeszynska, “but in a very practical, grounded way.”

The next wave of AI is thought to be about contextual intelligence, helping identify patterns, tracking change over time and turning everyday markers from cycle data, wearables, and mental health check-ins into actionable insights for clinicians and users.

Menstrual blood becomes a major diagnostic tool

Menstrual blood, long-overlooked, will also emerge as an important source of health insight. Period products will evolve beyond being ‘passive absorbents’ to ‘data-enabled health touchpoints’, Strzeszynska says, measuring key markers to support the diagnosis of conditions such as fibroids, anaemia, adenomyosis and even suspected endometriosis.

“We’ll move beyond subjective labels like ‘light’, ‘medium’ or ‘heavy’ periods and towards measurable bleeding metrics, actual blood volume, clot size, flow characteristics and how these change across cycles,” she adds.

“By 2026, using your period as a long-term health data signal won’t feel radical. It will feel like the obvious next step in closing the evidence gap in women’s health.”

Maternal mental health moves centre stage

One of the most important areas of innovation in women’s health next year will be centred around maternal mental health, says Shubareva-Epshtein.

“Anxiety and emotional well-being play a critical role across fertility, pregnancy, birth and postpartum, yet they have historically been underaddressed,” she continues.

Femtech startups are now beginning to integrate emotional check-ins, validated screening tools, and access to midwives, therapists and coaches into their digital platforms.

This moves the sector from simply offering reactive support to playing an active role in prevention.

“Femtech is beginning to recognise mental health as a core component of care rather than an add-on or nice-to-have,” Shubareva-Epshtein adds.

“The impact will be profound, helping to prevent trauma rather than react to it. Together, these shifts represent an opportunity to build women’s health solutions that feel human, supportive and genuinely transformative.”

A new, evidence-led consumer mindset

Women are entering 2026 more informed, more questioning and more empowered than ever when it comes to their health.

Google search trends reveal a population that is more proactive and engaged than ever, with searches around menstrual cycle phases, cholesterol management, heart-rate training, skin cancer detection and libido support rising dramatically, according to research by Bupa Health Clinics.

But as Dr Samantha Wild, clinical lead for Women’s Health and GP, Bupa Health Clinics, notes, this empowerment comes with a need for caution.

While credible, science-backed tools will thrive, innovators should be prepared to meet consumers’ rising expectations for evidence-led solutions.

“Good health is personal to everyone, says Wild.

“It comes from taking care of your body in the long term, and rarely from a quick fix. If you’re looking to make a change to your lifestyle, make choices that are scientifically backed, right for you, and proven to help over the long term.

“If you’re concerned about your health, whether it be your skin cancer risk or menstrual cycle, your first port of call should always be a health professional.

“Health professionals can work through your concerns and suggest credible, safe and long-term plans to help get your health where you’d like it to be.”

Genomics and DNA sequencing go mainstream

Also powering the shift towards more personalised care is the surge in popularity of DNA and genome testing, which is becoming more mainstream as private sequencing becomes increasingly accessible.

According to Bupa Health Clinics, the UK has seen an explosion in public interest in DNA testing, with ‘DNA nutrition’ searches rising 11-fold and genome sequencing searches doubling.

Women are increasingly using genetic insights to personalise nutrition, make decisions around medication and introduce disease-prevention strategies.

“Personalisation in healthcare looks set to become even bigger in 2026,” Wild adds.

“In the past, you needed a referral from a GP to have genetic testing via the NHS.

“However, it’s possible to opt for a full genome or DNA health test privately now, allowing many more people in the UK to better understand their genetic makeup and health profiles.”

Growing momentum, but funding gaps remain

Femtech is now a fast-growing sector, projected to hit $75 billion globally. But despite the momentum, funding remains fragmented.

While fertility solutions are thriving, innovation in menopause, sexual health, and non-hormonal contraception lags due to funding gaps, Lewis says.

“Sustained investment and cross-sector collaboration are vital to ensure innovation benefits all aspects of women’s health, she tells Femtech World.

But as pressure mounts and we see more drive from governments, investors, and professional bodies to address longstanding gender health gaps, 2026 could be the time we start to see tangible change.

“The UK is emerging as a key hub, supported by the government’s Women’s Health Strategy and new research from the Royal College of Obstetricians and Gynaecologists outlining top priorities,” Lewis continues.

“Investors are bullish, with startups eyeing IPOs amid rapid AI adoption, signalling both financial opportunity and cultural change.”

What this means for femtech in 2026

Speaking to experts across the sector, a singular theme emerges for femtech in 2026. After decades of being overlooked and kept in the dark, women are finally gaining meaningful insight into their own bodies.

Wearables will feed real-time data, AI will interpret patterns, and all of this will be harnessed to deliver more precise, preventative and personalised care.

This shift is not just about developing better technology but potentially transforming women’s experiences of healthcare.